Sei Investments Co. Sells 43,084 Shares of Aveanna Healthcare Holdings Inc. $AVAH

Sei Investments Co. trimmed its position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 53.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 37,195 shares of the company’s stock after selling 43,084 shares during the period. Sei Investments Co.’s holdings in Aveanna Healthcare were worth $240,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of AVAH. Caitong International Asset Management Co. Ltd raised its position in shares of Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock valued at $27,000 after buying an additional 2,400 shares in the last quarter. Summit Securities Group LLC acquired a new stake in shares of Aveanna Healthcare during the 1st quarter worth approximately $53,000. Quantbot Technologies LP acquired a new stake in shares of Aveanna Healthcare during the 2nd quarter worth approximately $43,000. Entropy Technologies LP bought a new position in Aveanna Healthcare in the third quarter valued at approximately $107,000. Finally, Oxford Asset Management LLP bought a new position in Aveanna Healthcare in the second quarter valued at approximately $64,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Key Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Q2 results exceeded expectations. Revenue increased 13.7% year over year to $670.5 million, while net income rose to $40.3 million from $27.0 million. Adjusted EBITDA reached $95.4 million, up 8.0%, and adjusted EPS of $0.22 topped analyst estimates of $0.19. Aveanna Healthcare Second Quarter Financial Results and Revised 2026 Guidance
• Positive Sentiment: Management raised full-year guidance. Aveanna now expects 2026 revenue above $2.68 billion, compared with its previous $2.63 billion-$2.65 billion range, and adjusted EBITDA above $365 million, up from $338 million-$342 million. The company cited reimbursement improvements, preferred-payer relationships and continued demand for complex home care. AVAH Q2 Earnings Call Highlights Higher Growth Targets
• Positive Sentiment: Analysts lifted their price targets. BMO Capital Markets raised its target from $10 to $14 and maintained an “outperform” rating. UBS raised its target from $8 to $13, although it retained a “neutral” rating. The revisions signal improved earnings expectations and support the stock’s recent strength. Benzinga analyst price target updates
• Neutral Sentiment: Growth is concentrated in Private Duty Services, which generates roughly 83% of revenue. Rapid revenue expansion is offsetting pressure on gross margins across business segments, making margin trends an important focus for investors. Aveanna Healthcare Q2 Earnings Report

Analyst Ratings Changes

Several brokerages have commented on AVAH. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $10.00 to $11.00 in a research report on Friday, May 15th. BMO Capital Markets raised their target price on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a report on Friday. Wall Street Zen lowered Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. Finally, Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, Aveanna Healthcare presently has an average rating of “Moderate Buy” and an average target price of $11.78.

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the stock in a transaction dated Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $19,376,470.35. Following the completion of the transaction, the insider directly owned 10,112,123 shares in the company, valued at approximately $80,998,105.23. This trade represents a 19.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Patrick A. Cunningham sold 125,000 shares of Aveanna Healthcare stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $7.59, for a total value of $948,750.00. Following the sale, the insider directly owned 212,755 shares in the company, valued at $1,614,810.45. The trade was a 37.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 31,305,664 shares of company stock worth $215,555,910. 5.30% of the stock is currently owned by insiders.

Aveanna Healthcare Stock Performance

Shares of Aveanna Healthcare stock opened at $12.32 on Monday. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $12.52. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. The firm has a market capitalization of $2.69 billion, a P/E ratio of 10.02, a P/E/G ratio of 1.22 and a beta of 1.90. The company’s 50 day moving average price is $8.97 and its two-hundred day moving average price is $7.75.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million for the quarter, compared to analysts’ expectations of $638.61 million. On average, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current fiscal year.

Aveanna Healthcare Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.